Concepedia

Tricia L. Johnson

TL

Statistics

Publications

4

Citations

126

H-Index

4

Active since

2001

Affiliations

Merck Serono Ltd. (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Tricia L. Johnson is an author at Merck Serono Ltd. (United Kingdom) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2001–2018

4

Publications

4

Quinazolines as cyclin dependent kinase inhibitors

Thais M. Sielecki, Tricia L. Johnson, Jie Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 86 citations · Full text

, , +10

Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptor

Gregori J. Morriello, Gary G. Chicchi, Tricia L. Johnson et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 19 citations · Full text

, , +4

Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists

Gregori J. Morriello, Sander G. Mills, Tricia L. Johnson et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 11 citations · Full text

, , +10

Multi-year Study of PAHs in Mainstream Cigarette Smoke

Bryan Hearn, Yan S. Ding, Clifford H. Watson et al. · Tobacco Regulatory Science · 2018 · 10 citations · Full text

, , +11

1–4 of 4